To include your compound in the COVID-19 Resource Center, submit it here.

Regulators agree on endpoints for COVID-19 therapeutics trials

International regulators have agreed upon the best endpoints for use in clinical trials for COVID-19 therapeutics, with mortality the key endpoint for hospitalized

Read the full 239 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE